Merck 2010 Annual Report Download - page 140

 Merck Serono
Consumer
Health Care Pharmaceuticals Merck Millipore * Performance Materials * Chemicals Corporate and Other Group
EUR million 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009
Sales 5,409.0 4,993.8 469.7 464.9  5,458.7 1,673.5 921.2 1,376.7 997.8  1,919.0 – –  7,377.7
Royalty, license and commission income 344.5 351.1 2.3 2.1  353.2 7.2 8.2 7.7 7.9  16.1 – –  369.3
Total revenues 5,753.5 5,344.9 472.0 467.0  5,811.9 1,680.7 929.4 1,384.4 1,005.7  1,935.1 – –  7,747.0
Gross margin 4,792.8 4,485.5 316.9 319.5  4,805.0 871.0 434.5 924.5 478.2  912.7 – –  5,717.7
Marketing and selling expenses ** –1,451.4 –1,316.1 –235.9 –211.9  –1,528.0 –427.7 –231.8 –116.6 –99.2  –331.0 –2.9 –0.3  –1,859.3
Royalty, license and commission expenses ** –456.2 –403.0 –1.2 –1.5  –404.5 –9.9 –5.7 –9.7 –2.8  –8.5 – –  –413.0
Administration expenses –269.9 –263.6 –24.7 –24.3  –287.9 –76.4 –43.1 –38.5 –35.8  –78.9 –68.7 –58.1  –424.9
Other operating expenses and income –169.6 –317.4 –12.1 –9.9  –327.3 –140.0 –14.0 –47.5 –8.1  –22.1 –21.2 –23.3  –372.7
Research and development –1,167.1 –1,183.6 –24.9 –19.5  –1,203.1 –78.0 –32.5 –127.1 –109.0  –141.5 – –  –1,344.6
Operating result 565.1 354.7 13.9 48.3  403.0 44.0 106.5 580.0 217.8  324.3 –89.5 –78.4  648.9
Exceptional items 68.6 –39.8 – –  –39.8 – 10.6 –1.0 1.2  11.8 –68.4 –  –28.0
Earnings before interest and tax (EBIT) 633.7 314.9 13.9 48.3  363.2 44.0 117.1 579.0 219.0  336.1 –157.9 –78.4  620.9
Net operating assets 10,359.7 10,015.9 310.8 336.0  10,351.9 6,486.7 781.2 1,238.6 1,176.2  1,957.4 74.7 37.4  12,346.7
Segment liabilities –1,268.9 –1,078.2 –86.4 –76.9  –1,155.1 –374.3 –111.5 –153.9 –118.7  –230.2 –14.9 –15.7  –1,401.0
Capital spending on property, plant
and equipment 247.7 317.2 6.9 10.0  327.2 80.3 57.6 59.1 82.1  139.7 2.2 0.4  467.3
Investments in intangible assets 85.1 74.8 1.3 1.4  76.2 7.2 4.9 3.6 7.5  12.4 7.0 8.0  96.6
Depreciation and amortization –766.5 –749.6 –11.6 –9.5  –759.1 –172.7 –46.0 –98.2 –87.6  –133.6 –3.2 –1.9  –894.6
Impairment losses –171.0 –99.1 –7.1 –  –99.1 –11.0 –1.4 –16.4 –8.1  –9.5 –0.2 –0.8  –109.4
Net cash flows from operating activities 1,590.1 1,250.7 46.6 58.0  1,308.7 252.7 174.7 610.4 392.9  567.6 –717.2 –505.0  1,371.3
Net cash flows from investing activities –292.0 –386.3 –1.1 –9.1  –395.4 –4,924.6 –52.1 –68.2 –105.0  –157.1 1,403.5 –1,608.2  –2,160.7
Free cash flow 1,298.1 864.4 45.5 48.9  913.3 –4,671.9 122.6 542.2 287.9  410.5 –736.4 –511.4  812.4
Underlying free cash flow 1,307.8 866.8 45.5 48.9  915.7 263.4 127.7 548.8 304.0  431.7 –495.7 –495.8  851.6
FCR in % 22.7 16.2 9.6 10.5  15.8 15.7 13.7 39.6 30.2  22.3 – –  11.0
ROS in % 9.8 6.6 2.9 10.3  6.9 2.6 11.5 41.9 21.7  16.8 – –  8.4



 Germany France Switzerland Rest of Europe North America Latin America Asia Africa, Australasia Group
EUR million 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009 2010 2009
Sales by customer location 779.4 708.1 714.2 684.6 111.4 84.9 2,141.8 1,896.1 1,529.6 1,171.3 1,080.6 941.8 2,305.5 1,685.6 266.4 205.3  7,377.7
Sales by company location 1,315.0 1,113.4 810.4 796.1 149.9 167.0 1,819.4 1,601.8 1,512.6 1,146.0 1,054.0 923.2 2,114.9 1,520.8 152.7 109.4  7,377.7
Total revenues 1,333.2 1,137.5 821.6 806.0 364.6 388.8 1,836.3 1,619.1 1,514.8 1,147.3 1,055.9 926.7 2,211.5 1,612.2 152.7 109.4  7,747.0
Intangible assets 184.0 180.0 343.9 217.7 6,701.0 6,648.2 2,452.1 209.8 2,537.9 120.2 15.4 13.6 249.2 208.7 0.6 0.2  7,598.4
Property, plant and equipment 1,088.5 1,113.5 140.0 82.4 987.3 815.7 399.5 238.6 358.6 116.1 79.7 79.3 181.1 156.2 6.8 5.8  2,607.6
Research and development –649.7 –636.4 –49.4 –46.3 –566.4 –553.4 –32.8 –37.1 –56.8 –32.9 –7.3 –7.3 –31.4 –28.1 –3.3 –3.1  –1,344.6
Number of employees 10,340 9,904 2,916 1,985 2,407 2,275 6,016 4,412 4,909 2,051 4,546 4,272 8,681 7,462 747 701  33,062


136 Merck Annual Report 2010